BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9657283)

  • 1. Stimulation of liver heme oxygenase in hexachlorobenzene-induced hepatic porphyria.
    Stonard MD; Poli G; De Matteis F
    Arch Toxicol; 1998 May; 72(6):355-61. PubMed ID: 9657283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme metabolism after discontinued hexachlorobenzene administration in rats: possible irreversible changes and biomarker for hexachlorobenzene persistence.
    De Catabbi SCB ; Aldonatti C; de Viale LC
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Sep; 127(2):165-75. PubMed ID: 11083027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
    Mylchreest E; Charbonneau M
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):23-33. PubMed ID: 9221820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an experimental model for the study of hexachlorobenzene-induced hepatic porphyria in the rat.
    Krishnan K; Brodeur J; Charbonneau M
    Fundam Appl Toxicol; 1991 Oct; 17(3):433-41. PubMed ID: 1794647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of oxidative metabolism in hexachlorobenzene-induced porphyria and thyroid hormone homeostasis: a comparison with pentachlorobenzene in a 13-week feeding study.
    den Besten C; Bennik MH; Bruggeman I; Schielen P; Kuper F; Brouwer A; Koeman JH; Vos JG; Van Bladeren PJ
    Toxicol Appl Pharmacol; 1993 Apr; 119(2):181-94. PubMed ID: 8480328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexachlorobenzene impairs glucose metabolism in a rat model of porphyria cutanea tarda: a mechanistic approach.
    Mazzetti MB; Taira MC; Lelli SM; Dascal E; Basabe JC; de Viale LC
    Arch Toxicol; 2004 Jan; 78(1):25-33. PubMed ID: 12898129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexachlorobenzene-induced alterations on neutral and acidic sphingomyelinases and serine palmitoyltransferase activities. A time course study in two strains of rats.
    Billi de Catabbi SC; Setton-Advruj CP; Sterin-Speziale N; San Martín de Viale LC; Cochón AC
    Toxicology; 2000 Aug; 149(2-3):89-100. PubMed ID: 10967406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls.
    Smith AG; Francis JE; Green JA; Greig JB; Wolf CR; Manson MM
    Biochem Pharmacol; 1990 Nov; 40(9):2059-68. PubMed ID: 2173599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
    Adjarov DG; Elder GH
    IARC Sci Publ; 1986; (77):467-9. PubMed ID: 3596742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arachidonic acid metabolism is disrupted after hexachlorobenzene treatment.
    Billi de Catabbi SC; Faletti A; Fuentes F; San Martín de Viale LC; Cochón AC
    Toxicol Appl Pharmacol; 2005 Apr; 204(2):187-95. PubMed ID: 15808524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationships in hexachlorobenzene-induced porphyria.
    Kennedy SW; Wigfield DC
    Biochem Pharmacol; 1990 Sep; 40(6):1381-8. PubMed ID: 2403392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sulfur-containing metabolites of hexachlorobenzene on the heme metabolic enzymes in rat liver.
    Kato Y; Konishi S; Yamada S; Kimura R
    J Pharmacobiodyn; 1990 May; 13(5):278-84. PubMed ID: 2273443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria.
    Smith AG; Francis JE; Dinsdale D; Manson MM; Cabral JR
    Carcinogenesis; 1985 Apr; 6(4):631-6. PubMed ID: 3986965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid and DNA oxidative damage in experimentally induced hepatic porphyria in C57BL/10ScSn mice.
    Horváth ME; Faux SP; Blázovics A; Fehér J
    Z Gastroenterol; 2001 Jun; 39(6):453-5, 458. PubMed ID: 11475000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of hexachlorobenzene-induced porphyria in rats. Effect of phenobarbitone pretreatment.
    Wainstok de Calmanovici R; Ríos de Molina MC; Taira de Yamasato MC; Tomio JM; San Martin de Viale LC
    Biochem J; 1984 Mar; 218(3):753-63. PubMed ID: 6721832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function and thyroxine metabolism in hexachlorobenzene-induced porphyria.
    Kleiman de Pisarev DL; Rios de Molina MC; San Martin de Viale LC
    Biochem Pharmacol; 1990 Mar; 39(5):817-25. PubMed ID: 2310407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice.
    Hahn ME; Gasiewicz TA; Linko P; Goldstein JA
    Biochem J; 1988 Aug; 254(1):245-54. PubMed ID: 2845946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E protects against iron-hexachlorobenzene induced porphyria and formation of 8-hydroxydeoxyguanosine in the liver of C57BL/10ScSn mice.
    Horváth ME ; Faux SP; Smith AG; Blázovics A; van der Looij M; Fehér J; Cheeseman KH
    Toxicol Lett; 2001 May; 122(1):97-102. PubMed ID: 11397561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria.
    Alleman MA; Koster JF; Wilson JH; Edixhoven-Bosdijk A; Slee RG; Kroos MJ; von Eijk HG
    Biochem Pharmacol; 1985 Jan; 34(2):161-6. PubMed ID: 3966921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.
    Doss M; Schermuly E; Koss G
    Ann Clin Res; 1976; 8 Suppl 17():171-81. PubMed ID: 1008488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.